Step by Stepa HemeOncBuddy patient portal

Docetaxel

Illustration: Docetaxel

Say it: doh-seh-TAX-el · Brand names: Taxotere

Docetaxel is a chemotherapy medicine that stops cancer cells from dividing.

What it is

Cells need tiny inner tubes to split into two new cells. Docetaxel locks these tubes in place so the cell cannot divide. This makes the cancer cell die.

Often used for

How you get it

Docetaxel is given through a vein (IV) in a clinic. The infusion takes about 1 hour. It is often given once every 3 weeks. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

Questions to ask

Part of these treatment plans

Side effect guides

Sources

Quick answers

What is Docetaxel?
Docetaxel is a chemotherapy medicine that stops cancer cells from dividing. Brand names: Taxotere.
What is Docetaxel used for?
breast cancer; lung cancer; prostate cancer; stomach cancer; head and neck cancer.
How is Docetaxel given?
Docetaxel is given through a vein (IV) in a clinic. The infusion takes about 1 hour. It is often given once every 3 weeks. Your schedule may be different.
What are the common side effects of Docetaxel?
Hair loss. Feeling very tired. Nail changes, such as dark or loose nails. Mouth sores. Swelling in the legs or feet from extra fluid. Numbness or tingling in the hands or feet. Diarrhea or upset stomach. Low blood counts.
When should I call my care team while taking Docetaxel?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher; Chills, a sore throat, a cough, or burning when you pee (signs of infection); Itching, rash, swelling of the face or lips, or trouble breathing during or soon after the infusion; Sudden weight gain, swelling that gets worse, or trouble breathing when lying flat; Blurry vision or a change in how you see; Throwing up or diarrhea so bad you cannot keep fluids down; A bad rash, blisters, or peeling skin.
Which chemotherapy plans include Docetaxel?
FLOT, TC, TCHP, THP.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.